Nefense®, a company focused on advanced clinical hygiene and airway health solutions, has officially launched its Hypochlorous Acid (HOCl) nasal spray line. The announcement, made on June 4, 2026, introduces a comprehensive product expansion that delivers an age-specific approach to airway health, respiratory hygiene, and nasal wellness. The new line includes formulations tailored for adults, children, and infants, addressing the need for safe and effective nasal care across different age groups.
The flagship product, Hyponasal spray, is designed as a gentle, clinical-grade biocleanse that flushes irritants, provides immediate soothing relief, and supports natural respiratory defenses without the use of harsh chemicals or steroids. According to Nefense, the spray is powered by hypochlorous acid, a substance known for its broad-spectrum antimicrobial and anti-inflammatory properties. This formulation aims to neutralize bacteria and viruses, help prevent upper respiratory infections, and combat seasonal allergies.
The launch of this product line comes as consumers increasingly seek non-pharmaceutical options for respiratory health. Hypochlorous acid is naturally produced by the human immune system and has gained attention for its safety and efficacy in wound care and disinfection. Nefense's application of this compound in a nasal spray format represents a novel approach to daily airway hygiene.
Nefense emphasizes that its products are developed in collaboration with doctors and ENT specialists. The company's portfolio also includes XyloClean, a xylitol-based nasal spray designed to moisturize and rebalance nasal passages. Many clinics and practices nationwide offer in-store purchases of the Nefense nasal spray family.
The implications of this announcement are significant for public health. By providing age-specific formulations, Nefense addresses a gap in the market where children and infants often lack tailored respiratory hygiene products. The antimicrobial action of hypochlorous acid could reduce the reliance on antibiotics for upper respiratory infections, potentially slowing antimicrobial resistance. Additionally, for allergy sufferers, the spray offers a drug-free method to manage symptoms.
Nefense's focus on bridging daily hygiene, airway health, restorative sleep, and overall wellness aligns with growing consumer interest in proactive health measures. As respiratory viruses continue to pose public health challenges, products like the Hyponasal spray may become part of routine hygiene practices. The company's commitment to science-driven solutions and collaboration with medical professionals lends credibility to its claims.
For more information, the full announcement, including downloadable images and bios, is available on Newsworthy.ai. The press release was distributed by Reportable, Inc.
